Mechanisms by which SGN-40, a humanized anti-cd40 antibody, induces cytotoxicity in human multiple myeloma cells: Clinical implicationsTAI, Yu-Tzu; CATLEY, Laurence P; RICHARDSON, Paul et al.Cancer research (Baltimore). 2004, Vol 64, Num 8, pp 2846-2852, issn 0008-5472, 7 p.Article

Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survivalBURGER, Renate; BAKKER, Frank; GRAMATZKI, Martin et al.British journal of haematology. 2003, Vol 123, Num 5, pp 869-878, issn 0007-1048, 10 p.Article

Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistanceCHAUHAN, Dharminder; LI, Guilan; BURGER, Renate et al.Blood. 2003, Vol 102, Num 9, pp 3379-3386, issn 0006-4971, 8 p.Article

Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of β1-integrin and phosphatidylinositol 3'-kinase/AKT signalingTAI, Yu-Tzu; PODAR, Klaus; RICHARDSON, Paul et al.Cancer research (Baltimore). 2003, Vol 63, Num 18, pp 5850-5858, issn 0008-5472, 9 p.Article

GW654652, the pan-inhibitor of VEGF receptors, blocks the growth and migration of multiple myeloma cells in the bone marrow microenvironmentPODAR, Klaus; CATLEY, Laurence P; KUMAR, Rakesh et al.Blood. 2004, Vol 103, Num 9, pp 3474-3479, issn 0006-4971, 6 p.Article

Proteasomal degradation of topoisomerase I is preceded by c-Jun NH₂-Terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myelomaCATLEY, Laurence; TAI, Yu-Tzu; RICHARDSON, Paul et al.Cancer research (Baltimore). 2004, Vol 64, Num 23, pp 8746-8753, issn 0008-5472, 8 p.Article

The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cellsHÖNEMANN, Dirk; CHATTERJEE, Manik; SAVINO, Rocco et al.International journal of cancer. 2001, Vol 93, Num 5, pp 674-680, issn 0020-7136Article